Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

273 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patterns of leukocyte recovery predict infectious complications after CD19 CAR-T cell therapy in a real-world setting.
Thakkar A, Cui Z, Peeke SZ, Shah N, Pradhan K, Lombardo A, Khatun F, Mustafa J, De Castro A, Gillick K, Joseph F, Naik A, Rahman S, D'Aiello A, Elkind R, Sakalian S, Fehn K, Wright K, Abreu M, Townsend-Nugent L, Chambers N, Mathew R, Binakaj D, Nelson R, Palesi C, Paroder M, Uehlinger J, Wang Y, Shi Y, Zang X, Wang H, Nishimura C, Ren X, Steidl UG, Gritsman K, Janakiram M, Kornblum N, Derman O, Mantzaris I, Shastri A, Bartash R, Puius Y, McCort M, Goldfinger M, Bachier-Rodriguez L, Verma A, Braunschweig I, Sica RA. Thakkar A, et al. Stem Cell Investig. 2021 Sep 6;8:18. doi: 10.21037/sci-2021-008. eCollection 2021. Stem Cell Investig. 2021. PMID: 34631871 Free PMC article.
Seroconversion rates following COVID-19 vaccination among patients with cancer.
Thakkar A, Gonzalez-Lugo JD, Goradia N, Gali R, Shapiro LC, Pradhan K, Rahman S, Kim SY, Ko B, Sica RA, Kornblum N, Bachier-Rodriguez L, McCort M, Goel S, Perez-Soler R, Packer S, Sparano J, Gartrell B, Makower D, Goldstein YD, Wolgast L, Verma A, Halmos B. Thakkar A, et al. Cancer Cell. 2021 Aug 9;39(8):1081-1090.e2. doi: 10.1016/j.ccell.2021.06.002. Epub 2021 Jun 5. Cancer Cell. 2021. PMID: 34133951 Free PMC article.
Efficacy of booster doses in augmenting waning immune responses to COVID-19 vaccine in patients with cancer.
Shapiro LC, Thakkar A, Campbell ST, Forest SK, Pradhan K, Gonzalez-Lugo JD, Quinn R, Bhagat TD, Choudhary GS, McCort M, Sica RA, Goldfinger M, Goel S, Anampa JD, Levitz D, Fromowitz A, Shah AP, Sklow C, Alfieri G, Racine A, Wolgast L, Greenberger L, Verma A, Halmos B. Shapiro LC, et al. Among authors: thakkar a. Cancer Cell. 2022 Jan 10;40(1):3-5. doi: 10.1016/j.ccell.2021.11.006. Epub 2021 Nov 16. Cancer Cell. 2022. PMID: 34838186 Free PMC article.
Impact of COVID-19 on case fatality rate of patients with cancer during the Omicron wave.
Lee M, Quinn R, Pradhan K, Fedorov K, Levitz D, Fromowitz A, Thakkar A, Shapiro LC, Kabarriti R, Ruiz RE, Andrews EM, Thota R, Chu E, Kalnicki S, Goldstein Y, Loeb D, Racine A, Halmos B, Mehta V, Verma A. Lee M, et al. Among authors: thakkar a. Cancer Cell. 2022 Apr 11;40(4):343-345. doi: 10.1016/j.ccell.2022.02.012. Epub 2022 Feb 22. Cancer Cell. 2022. PMID: 35219358 Free PMC article. No abstract available.
Efficacy and safety of CAR-T cell therapy in minorities.
Thakkar A, Abreu M, Pradhan K, Sica RA, Shastri A, Kornblum N, Shah N, Mantzaris I, Gritsman K, Feldman E, Elkind R, Green-Lorenzen S, Verma A, Braunschweig I, Goldfinger M. Thakkar A, et al. Bone Marrow Transplant. 2022 Jul;57(7):1187-1190. doi: 10.1038/s41409-022-01670-1. Epub 2022 Apr 28. Bone Marrow Transplant. 2022. PMID: 35484206 No abstract available.
High seroconversion rates amongst black and Hispanics with hematologic malignancies after SARS-CoV-2 vaccination.
Shapiro LC, Thakkar A, Gali R, Gonzalez-Lugo JD, Bazarbachi AH, Rahman S, Pradhan K, Fehn K, Abreu M, Kornblum N, Gritsman K, Goldfinger M, Shastri A, Mantzaris I, Braunschweig I, Halmos B, Verma A, McCort M, Bachier-Rodriguez L, Sica RA. Shapiro LC, et al. Among authors: thakkar a. Leuk Lymphoma. 2022 Oct;63(10):2484-2488. doi: 10.1080/10428194.2022.2074988. Epub 2022 May 20. Leuk Lymphoma. 2022. PMID: 35593019 No abstract available.
[No title available]
[No authors listed] [No authors listed] PMID: 36164124
Outcome of Stem Cell Transplantation in HTLV-1-Associated North American Adult T-Cell Leukemia/Lymphoma.
Bazarbachi AH, Reef D, Narvel H, Patel R, Al Hamed R, Vikash S, Neupane K, Atalla E, Thakkar A, Rahman S, Shah U, Adrianzen-Herrera D, Quinn R, Zareef S, Rabinovich E, De Castro A, Joseph F, Gillick K, Mustafa J, Khatun F, Lombardo A, Townsend-Nugent L, Abreu M, Chambers N, Elkind R, Shi Y, Wang Y, Derman O, Gritsman K, Steidl U, Goldfinger M, Kornblum N, Shastri A, Mantzaris I, Bachier-Rodriguez L, Shah N, Cooper D, Verma A, Ye BH, Janakiram M, Sica RA. Bazarbachi AH, et al. Among authors: thakkar a. Clin Hematol Int. 2023 Jun;5(2-3):78-91. doi: 10.1007/s44228-023-00032-y. Epub 2023 Mar 15. Clin Hematol Int. 2023. PMID: 36918485 Free PMC article.
Study of efficacy and longevity of immune response to third and fourth doses of COVID-19 vaccines in patients with cancer: A single arm clinical trial.
Thakkar A, Pradhan K, Duva B, Carreno JM, Sahu S, Thiruthuvanathan V, Campbell S, Gallego S, Bhagat TD, Rivera J, Choudhary G, Olea R, Sabalza M, Shapiro LC, Lee M, Quinn R, Mantzaris I, Chu E, Will B, Pirofski LA, Krammer F, Verma A, Halmos B. Thakkar A, et al. Elife. 2023 Mar 28;12:e83694. doi: 10.7554/eLife.83694. Elife. 2023. PMID: 36975207 Free PMC article. Clinical Trial.
CLINICAL TRIAL NUMBER: NCT05016622. People with cancer have a higher risk of death or severe complications from COVID-19. As a result, vaccinating cancer patients against COVID-19 is critical. ...But limited information is available about how well booster doses prot …
CLINICAL TRIAL NUMBER: NCT05016622. People with cancer have a higher risk of death or severe complications from COVID-19. As a …
273 results